Zusammenfassung
Acquired von Willebrand disease (AvWD) is a bleeding disorder strikingly similar to congenital von Willebrand disease in terms of clinical manifestations and laboratory findings being characterized by a prolonged bleeding time and low levels of factor VIII von Willebrand factor (FVIII/vWf) complex, but without a family history of a congenital bleeding tendency and absence of abnormal bleeding after hemostatic challenges.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Ivy AC, Nelson D, Bucher GNH (1941) The standardization of certain factors in the cutaneous “venostasis” bleeding time technique. J Lab Clin Med 26: 1812
van Genderen PJJ, Vink T, Michiels JJ, van’t Veer MB, Sixma JJ, van Vliet HHDM (1994) Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of the von Willebrand factor to collagen. Blood 84: 3378
Ceika J (1982) Enzyme immunoassay for FVIII-related antigen Clin Chem 26: 1812
Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson JA (1975) A method for assaying von Willebrand factor ( Ristocetine cofactor ). Thromb Diath Haemorrh 34: 306
Brown JE, Bosak JO (1986) An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 43: 303
Brosstad F, Kjönniksen I, Rönning B, Stormorken H (1986) Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies. Thromb Haemost 55: 276
Kaspar CK, Aledort LM, Counts RB et al (1975) A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 34: 869
van Genderen PJJ, Michiels JJ, Bakker JJ, van’t Veer MB (1994) Effectiveness of high-dose intravenous gammaglobulin therapy in acquired von Willebrand’s disease. Vox Sang 67: 14
van Genderen PJJ, Papatsonis DNM, Michiels JJ, Wielenga JJ, Stibbe J, Huikeshoven FJM (1994) High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease. Postgrad Med J 70: 916
van Genderen PJJ, Terpstra W, Michiels JJ, Kapteijn L, van Vliet HHDD (1995) High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease. Thromb Haemost 73: 890
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Michiels, J.J. (1998). Acquired von Willebrand Disease in Monoclonal Gammapathies: Effectiveness of High-Dose Intravenous Gammaglobulin. In: Scharrer, I., Schramm, W. (eds) 27. Hämophilie-Symposion Hamburg 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80403-8_50
Download citation
DOI: https://doi.org/10.1007/978-3-642-80403-8_50
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62915-3
Online ISBN: 978-3-642-80403-8
eBook Packages: Springer Book Archive